Unloxcyt is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Unloxcyt is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameUnloxcyt
Authorized genericcosibelimab
Regular genericcosibelimab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Unloxcyt?
The original
–
–

Brand nameThe maker’s card

UNLOXCYT Copay Program

Savings card from Sun Pharma

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 an infusion

Sign up on unloxcyt.com 

Or call 1-855-865-9994.

In the maker’s words

“Patients with commercial health insurance who qualify to participate may pay as little as $0 for UNLOXCYT.”

From the maker’s offer on unloxcyt.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Unloxcyt itself, from the same company, sold without the brand name, and usually for less. For now Unloxcyt is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Unloxcyt is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

UNLOXCYT is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

Source: the FDA label for Unloxcyt (Sun Pharmaceutical Industries, Inc.), September 21, 2026. Full label on DailyMed 

Good to know